GGrantIndex
Sort

141,003 grants matching cytokine

Bifunctional T cell receptor based immunotherapeutics

$979,275
Hing C. Wong · Altor Bioscience. Llc · R44 · FY2011 · CA

Protein Modifications Involved in Cell Signaling

$979,268
Aleksandra Nita-Lazar · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI

Immunological Analysis of Brain Cancer

$979,154
Masaki Terabe · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Cardiovascular Disease Mechanisms in HIV Infected and Uninfected Veterans

$978,869
Matthew S Freiberg · University Of Pittsburgh At Pittsburgh · R01 · FY2008 · HL

TP508: A New Drug for Mitigating Lethal Effects of Radiatin Exposure

$978,663
Laurie E Sower · Chrysalis Biotherapeutics, Inc. · R44 · FY2014 · AI

Biomechanics and Inflammation in Osteoarthritis

$978,520
Farshid Guilak · Duke University · P01 · FY2008 · AR

GuMI: New In Vitro Platforms to Parse the Human Gut Epithelial-Microbiome-Immune Axis

$978,402
Rebecca L Carrier · Northeastern University · R01 · FY2019 · EB

Macrophage Polarization in Response to Infections and Inflammation

$978,019
Pradipta Ghosh · University Of California, San Diego · R01 · FY2022 · AI

Tailoring Mobile Health Technology to Reduce Obesity and ImproveCardiovascular Health in Resource-Limited Neighborhood Environments: A Multi-Level, Community-Based Physical Activity Intervention

$977,963
Tiffany Powell-Wiley · National Heart, Lung, And Blood Institute · ZIA · FY2022 · HL

Breast Cancer Survival: Lifestyle and Genetic Determinants

$977,864
Xiao-Ou Shu · Vanderbilt University · R01 · FY2009 · CA

Genetics Of The Dominantly Inherited Periodic Fever Syndromes

$977,863
Daniel L Kastner · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · Z01 · FY2008 · AR

Novel Strategies to Clear Bacteria from the CF Lung

$977,764
Saira Ahmad · Eldec Pharmaceuticals, Inc. · R44 · FY2023 · HL

Highly sensitive immunoassay for determination of biomarkers for neurodegenerative diseases

$977,713
Simon Bystryak · Allied Innovative Systems, Llc · R44 · FY2023 · AG

Gene Therapy for SCID-X1 using a self-inactivating (SIN) gammaretroviral vector

$977,629
David A Williams · Boston Children'S Hospital · U01 · FY2012 · AI

Viral Triggers of Alloimmunity and Autoimmunity in Pediatric Lung Transplantation

$977,544
Stuart C Sweet · Washington University · U01 · FY2009 · AI

Immunoglobulin Replacement Therapy and Infectious Complications After CD19-Targeted CAR-T-Cell Therapy

$977,273
Joshua Aiden Hill · Fred Hutchinson Cancer Center · R01 · FY2025 · CA

Chromatin and epigenetic memory

$977,211
Keiko Ozato · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2017 · HD

Development of KLS-13019 for Neuropathic Pain

$977,054
Douglas Eric Brenneman · Kannalife Sciences, Inc. · R42 · FY2021 · NS

The UIUC Neuroproteomics Center on Cell-Cell Signaling

$976,865
Jonathan V. Sweedler · University Of Illinois At Urbana-Champaign · P30 · FY2008 · DA

The Role of Host Factors in HIV Immunopathogenesis

$976,696
Anthony S. Fauci · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI

AADRC -- Mechanisms of Virus-Induced Asthma

$976,692
University Of Wisconsin Madison · P01 · FY2002 · AI

Combining receptor-targeted alpha particle therapy and immunotherapy to achieve complete responses in metastatic melanoma

$976,668
Michael King Schultz · Viewpoint Molecular Targeting, Inc. · R44 · FY2022 · CA

Exisulind for Chemoprevention of Lung Cancer

$976,569
H. Lee Moffitt Cancer Ctr &Res Inst · U01 · FY2003 · CA

IND Enabling Studies and Manufacturing Scale Up of Human Placental Extract to Prevent Surgical Necrotizing Enterocolitis

$976,322
Michael Bentley Berger · Plakous Therapeutics, Inc. · R44 · FY2025 · HD

Tailoring Mobile Health Technology to Reduce Obesity and ImproveCardiovascular Health in Resource-Limited Neighborhood Environments: A Multi-Level, Community-Based Physical Activity Intervention

$976,307
Tiffany Powell-Wiley · National Heart, Lung, And Blood Institute · ZIA · FY2021 · HL